financetom
Business
financetom
/
Business
/
What's Going On With Regencell Bioscience Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Regencell Bioscience Stock Today?
Jun 16, 2025 1:19 PM

Regencell Bioscience Holdings ( RGC ) shares are soaring Monday after the company’s 38-for-one forward stock split officially took effect.

What To Know: The split, announced at the beginning of June and distributed on June 13, gave shareholders 37 additional shares for each one they already owned. The stock began trading on a split-adjusted basis on Monday. The company stated that the goal of the split was to improve liquidity and make its shares more accessible to investors.

Regencell is an early-stage bioscience company based in Hong Kong. The company focuses on developing traditional Chinese medicine treatments for neurological disorders, specifically ADHD and autism spectrum disorder.

The stock split doesn't alter the company's fundamentals or financial outlook. The sharp spike in the company’s share price likely reflects speculative interest following the split. Investors may be reacting to the lower price per share post-split, which can drive short-term volume and volatility.

How To Buy RGC Stock

By now you're likely curious about how to participate in the market for Regencell Bioscience ( RGC ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

RGC Price Action: Regencell Bioscience ( RGC ) shares were up 276.5% at $59.21 at the time of publication Monday, according to Benzinga Pro.

Read Next:

Wall Street Roars Back As Iran Signals De-Escalation: Nasdaq 100 Nears All-Time High

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Trump's trade war imperils Spanish hatmaker's business with US Orthodox Jews
Trump's trade war imperils Spanish hatmaker's business with US Orthodox Jews
May 27, 2025
SEVILLE, Spain (Reuters) - A Spanish hatmaker warned that a 40-year tradition of supplying felt hats to Orthodox Jews in the U.S. risked becoming a casualty in President Donald Trump's trade war. The community, which is mainly based in New York and New Jersey, buys around 30,000 hats annually from the 140-year-old Fernandez y Roche Industrias Sombreras Españolas factory in...
Analysis-Europe's defence companies scramble for workers as business booms
Analysis-Europe's defence companies scramble for workers as business booms
May 27, 2025
VELKA BITES, Czech Republic/FRANKFURT/PARIS (Reuters) -Pavel Cechal reckons the Czech company he works for could easily generate more business for its missile and drone engines to double its workforce, if only he could find the staff. His dilemma is shared by many defence companies in Europe, where governments are ramping up spending on ammunition, tanks and other arms in response...
Cricut Insider Sold Shares Worth $1,094,610, According to a Recent SEC Filing
Cricut Insider Sold Shares Worth $1,094,610, According to a Recent SEC Filing
May 27, 2025
03:11 AM EDT, 05/27/2025 (MT Newswires) -- Arora Ashish, 10% Owner, Director, Chief Executive Officer, on May 21, 2025, sold 180,000 shares in Cricut ( CRCT ) for $1,094,610. Following the Form 4 filing with the SEC, Ashish has control over a total of 3,291,931 Class A common shares of the company, with 3,291,931 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1828962/000182896225000085/xslF345X05/wk-form4_1748039616.xml...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved